Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Carreira, P E; Carmona, L; Joven, B E; Loza, E; Andréu, J L; Riemekasten, G; Vettori, S; Balbir-Gurman, A; Airò, P; Walker, U; Damjanov, N; Matucci-Cerinic, M; Ananieva, L P; Rednic, S; Czirják, L; Distler, Oliver; Farge, D; Hesselstrand, R; Corrado, A; Caramaschi, P; Tikly, M; Allanore, Y; EUSTAR co-authors (2019). Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scandinavian Journal of Rheumatology, 48(1):42-51.

Saccardi, R; Freedman, M S; Sormani, M P; Atkins, H; Farge, D; Griffith, L M; Kraft, G; Mancardi, G L; Nash, R; Pasquini, M; Martin, R; Muraro, P A (2012). A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Multiple sclerosis (Houndmills, Basingstoke, England), 18(6):825-834.

Snowden, J A; Saccardi, R; Allez, M; Ardizzone, S; Arnold, R; Cervera, R; Denton, C; Hawkey, C; Labopin, M; Mancardi, G; Martin, R; Moore, J J; Passweg, J; Peters, C; Rabusin, M; Rovira, M; van Laar, J M; Farge, D (2012). Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 47(6):770-790.

Daikeler, T; Labopin, M; Di Gioia, M; Abinun, M; Alexander, T; Miniati, I; Gualandi, F; Fassas, A; Martin, T; Schwarze, C P; Wulffraat, N; Buch, M; Sampol, A; Carreras, E; Dubois, B; Gruhn, B; Güngör, T; Pohlreich, D; Schuerwegh, A; Snarski, E; Snowden, J; Veys, P; Fasth, A; Lenhoff, S; Messina, C; Voswinkel, J; Badoglio, M; Henes, J; Launay, D; Tyndall, A; Gluckman, E; Farge, D (2011). Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood, 118(6):1693-1698.

This list was generated on Thu Jun 20 08:58:29 2019 CEST.